Search Results

• • 1,813 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Angiogenesis and mast cell density as predictors of patient survival in squamous cell carcinoma of lung

  Authors:Ehsan Ullah, Abdul Nagi, and Muhammad AshrafFrom:Journal of Cancer Research and Therapeutics (Vol. 9, Issue 4) Peer-Reviewed

  October-December 20133,061 words Report 1680LByline: Ehsan. Ullah, Abdul. Nagi, Muhammad. Ashraf Background: Measuring the microvascular and mast cell density in squamous cell carcinoma of lung and correlating them with the patient survival may be helpful to...

• News & Views - Epigenomics

  From:Epigenomics (Vol. 6, Issue 1) Peer-Reviewed

  Feb. 2014284 words Brief article 1370LResearchers from Boston University School of Medicine (MA, USA) have identified a way to affect cell signaling that may prevent angiogenesis, the formation of new blood vessels, and therefore cancer growth. The...

• Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma

  Authors:Priya Dharmalingam, V. Roopesh Kumar, and Surendra VermaFrom:Indian Journal of Pathology and Microbiology (Vol. 56, Issue 4) Peer-Reviewed

  October-December 20133,857 words Report 1550LByline: Priya. Dharmalingam, V. Roopesh Kumar, Surendra. Verma Background: Vascular endothelial growth factor (VEGF) expression has been extensively studied in astrocytoma, whereas relatively less literature exists...

• Nanocomposite hydrogels: an emerging biomimetic platform for myocardial therapy and tissue engineering

  Author:Arghya PaulFrom:Nanomedicine (Vol. 10, Issue 9) Peer-Reviewed

  May 20152,339 words Report 1820LAuthor(s): Arghya Paul Keywords: cardiovascular therapy; hydrogel; nanohybrids; regenerative medicine; tissue engineering Repairing damaged heart muscles: the challenges Recent years have seen a significant...

• Correlating epidermal thickness and basement membrane length to angiogenesis in the centre and the periphery of vitiligo lesion

  Authors:Voudouris Stylianos, Ioannidis Eleftherios, Kavantzas Nikolaos, and Aroni KyriakiFrom:Indian Journal of Dermatology, Venereology, and Leprology (Vol. 78, Issue 3) Peer-Reviewed

  May-June 20121,134 words Letter to the editor 1650LByline: Voudouris. Stylianos, Ioannidis. Eleftherios, Kavantzas. Nikolaos, Aroni. Kyriaki Sir, In vitiligo it is well-documented that epidermis is thicker than in normally pigmented skin in frozen sections and...

• Photodynamic therapy with verteporfin for corneal neovascularization

  Author:Abdullah Al-TorbakFrom:Middle East African Journal of Ophthalmology (Vol. 19, Issue 2) Peer-Reviewed

  April-June 20122,382 words Report 1480LByline: Abdullah. Al-Torbak Purpose: To investigate the efficacy of photodynamic therapy (PDT) with verteporfin for the treatment of patients with corneal neovascularization. Materials and Methods: Retrospective...

• Subretinal hemorrhages associated with angioid streaks following a mild ocular trauma

  Authors:Fouad Chraibi, Bhallil Salima, Abdellaoui Meryem, Benatiya Idriss, and Hicham TahriFrom:Oman Journal of Ophthalmology (Vol. 5, Issue 3) Peer-Reviewed

  September-December 2012739 words Article 1430LByline: Fouad. Chraibi, Bhallil. Salima, Abdellaoui. Meryem, Benatiya. Idriss, Hicham. Tahri Introduction Angioid streaks (AS) are a rare ophthalmic finding. They are most frequently associated with pseudoxanthoma...

• Low VEGF expression in conceptus material and maternal serum AFP and [beta]-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages / lik trimester gebelik kayiplarinda, yetersiz anjiogenez'in gostergesi olarak konseptus matelyalinde dusuk VEGF ekspresyonu ye maternal serum AFP ye [beta]-hCG duzeyleri

  Authors:Gulsen Kutluer, Nedim Mahmut Cicek, Ozlem Moraloglu, Pervin Ertargin, Esma Sankaya, Ishak Mar, et al.From:Journal of the Turkish-German Gynecological Association (Vol. 13, Issue 2) Peer-Reviewed

  June 20125,193 words Report 1530LAbstract Objective: The aims of this study were to assess the relationship between early miscarriages and vascular endothelial growth factor (VEGF) expression and to determine the serum levels of first-trimester...

• Inflammatory choroidal neovascularization

  Authors:Piergiorgio Neri, Marta Lettieri, Cinzia Fortuna, Mara Manoni, and Alfonso GiovanniniFrom:Middle East African Journal of Ophthalmology (Vol. 16, Issue 4) Peer-Reviewed

  October-December 20094,706 words Clinical report Byline: Piergiorgio. Neri, Marta. Lettieri, Cinzia. Fortuna, Mara. Manoni, Alfonso. Giovannini Purpose and Methods: Choroidal neovascularization (CNV) can be a severe sight-threatening sequela, which can be secondary...

• Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane

  Authors:Mahesh Shanmugam, H. Mythri, and Nitin ShettyFrom:Indian Journal of Ophthalmology (Vol. 55, Issue 6) Peer-Reviewed

  November-December 2007680 words Case study 1410LByline: Mahesh. Shanmugam, H. Mythri, Nitin. Shetty Dear Editor, Parafoveal telangiectasia type IIA (PFT IIA) is characterized by abnormal retinal capillaries, graying of parafoveal retina, and right-angled venule...

• Clinical landscape of neovascular AMD is changing: emerging therapies provide increasing options in treating CNV

  Author:Peter KaiserFrom:Ophthalmology Times (Vol. 30, Issue 11) Peer-Reviewed

  June 1, 20052,229 words Disease/Disorder ove... 1540LIn the world of eye care, therapy for age-related macular degeneration (AMD) presents as an urgent medical need both now and for future generations. Neovascular AMD accounts for 20% of total AMD cases, but 90% of the...

• Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)

  Authors:Christian Herder, Burkhard Haastert, Sylvia Muller-Scholze, Wolfgang Koenig, Barbara Thorand, Roll Holle, et al.From:Diabetes (Vol. 54, Issue 12) Peer-Reviewed

  Dec. 20054,515 words Article Chemokines are crucial immune mediators in many physiological and pathophysiological conditions. Chemokines have been hypothesized to be involved in macrophage infiltration into adipose tissue in obesity and might...

• Stimulation of collateral artery growth: a potential treatment for peripheral artery disease

  Authors:Stephan H. Schirmer and Niels van RoyenFrom:Expert Review of Cardiovascular Therapy (Vol. 2, Issue 4) Peer-Reviewed

  July 1, 20046,452 words Report 1430LIn the course of peripheral artery occlusive disease, blood flow to peripheral tissue progressively decreases in a substantial portion of patients, leading to insufficient oxygenation and to the occurrence of...

• Angiogenesis in chronically ischaemic human heart following percutaneous myocardial revascularisation. (Scientific Letter)

  Authors:J.M. Cotton, M.R. Thomas, B.J. Dunmore, J. Salisbury, A.M. Shah, and N.P.J. BrindleFrom:Heart (Vol. 87, Issue 3) Peer-Reviewed

  Mar. 20021,289 words Article Patients with intractable angina and severe diffuse coronary artery disease not amenable to conventional revascularisation therapy have relatively few treatment options. A number of studies suggest myocardial laser...

• Fighting cancer with angiogenesis inhibitors: clinical trials suggest silver bullet may be losing its luster. (Lab Consumer)

  Author:Scott VeggebergFrom:The Scientist (Vol. 16, Issue 11) Peer-Reviewed

  May 27, 20021,583 words Article From disdain to hype, to mixed results in clinical trials, a sobering reality is setting in for researchers pursuing antiangiogenesis as a treatment for cancer: It is not as straightforward as once hoped. The idea is...

• Intravenous agent safe, effective anti-angiogenic compound: Phase I/II trial of squalamine lactate injections used to treat patients with classic, occult CNV

  Author:Cheryl GuttmanFrom:Ophthalmology Times (Vol. 29, Issue 18) Peer-Reviewed

  Sept. 15, 2004727 words Article Reviewed by Charles A. Garcia, MD Fort Lauderdale, FL--Intravenous squalamine lactate being developed by Geneara Corp. shows promise as a safe and effective treatment for choroidal neovascularization (CNV) associated...

• Angiogenesis in epithelian ovarian cancer. (Review)

  Authors:E.S. Bamberger and C.W. PerrettFrom:Molecular Pathology (Vol. 55, Issue 6) Peer-Reviewed

  Dec. 200212,814 words Article Angiogenesis, the development of new blood vessels from the existing vasculature, is an essential component of solid tumour growth and metastasis. Several angiogenic factors are expressed by many tumours, suggesting...

• A boost for tumor starvation: despite some setbacks, researchers developing antiangiogenesis treatments for cancer have persevered. Now the strategy is racking up new successes and earning credit even for conventional treatments. (News Focus)

  Author:Jean MarxFrom:Science (Vol. 301, Issue 5632) Peer-Reviewed

  July 25, 20032,550 words Article The past few years have been tough on companies trying to develop drags that fight cancer by attacking the blood vessels that feed tumors. Although these so-called antiangiogenesis drugs produced some small benefits in...

• Control of angiogenesis with synthetic heparin substitutes

  Authors:M. Judah Folkman, Paul B. Weisz, Madeleine M. Joullie, William W. Li, and William R. EwingFrom:Science (Vol. 243, Issue 4897) Peer-Reviewed

  Mar. 17, 19891,101 words Article Control of Angiogenesis with Synthetic Heparin Substitutes PERSISTENT CAPILLARY BLOOD VESsel growth is often associted with disease, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and...

• Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro

  Authors:Bryan Williams, Barbara Gallacher, Hashmukh Patel, and Carole OrmeFrom:Diabetes (Vol. 46, Issue 9) Peer-Reviewed

  Sept. 19975,745 words Article Hyperglycemia is an independent risk factor for the development of diabetic microvascular disease. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) is a potent cytokine family that induces...